MedTrace Logo

The Effect of Peroral Sodium Hyaluronate on the Skin

NCT07065110 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2025-07-15

No results posted yet for this study

Summary

A single-center, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the superiority of peroral sodium hyaluronate to placebo in improving the skin hydration and other skin-related parameters.

Conditions

  • Skin Conditions

Interventions

DIAGNOSTIC_TEST

Blood draw for the laboratory assessment

Blood draw for testing of metabolics.

DIETARY_SUPPLEMENT

Skin test panel

Testing of improving the skin hydration and other skin-related parameters.

DIETARY_SUPPLEMENT

HA gel

Participants obtained altogether 3 flasks with 500ml of SH60, SH 120 solution. They tooj 15 ml of the SH60 or SH120 aupplements (experimental group) once daily in the morning before breakfast for 3 months.

DIETARY_SUPPLEMENT

Xanthan gum

Participants obtained altogether 3 flasks of placebo solution. They took 15 mL of placebo solution (control group) once daily in the morning before breakfast for 3 months.

Sponsors & Collaborators

  • Contipro Pharma a.s.

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-17
Primary Completion
2024-12-13
Completion
2024-12-13

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07065110 on ClinicalTrials.gov